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ARTICLE

Endothelial IQGAP1 regulates leukocyte
transmigration by directing the LBRC to the site of
diapedesis
David P. Sullivan1, Prarthana J. Dalal1, Fanny Jaulin2, David B. Sacks3, Geri Kreitzer4, and William A. Muller1

Transendothelial migration (TEM) of leukocytes across the endothelium is critical for inflammation. In the endothelium, TEM
requires the coordination of membrane movements and cytoskeletal interactions, including, prominently, recruitment of the
lateral border recycling compartment (LBRC). The scaffold protein IQGAP1 was recently identified in a screen for LBRCinteracting proteins. Knockdown of endothelial IQGAP1 disrupted the directed movement of the LBRC and substantially
reduced leukocyte TEM. Expression of truncated IQGAP1 constructs demonstrated that the calponin homology domain is
required for IQGAP1 localization to endothelial borders and that the IQ domain, on the same IQGAP1 polypeptide, is required
for its function in TEM. This is the first reported function of IQGAP1 requiring two domains to be present on the same
polypeptide. Additionally, we show for the first time that IQGAP1 in the endothelium is required for efficient TEM in vivo. These
findings reveal a novel function for IQGAP1 and demonstrate that IQGAP1 in endothelial cells facilitates TEM by directing the
LBRC to the site of TEM.

Introduction
Inflammation evolved to eliminate pathogens, resolve injury,
and return the body to homeostasis. However, when improperly
regulated, whether overstimulated (reperfusion injury) or selfdirected (arthritis [Firestein and McInnes, 2017] and multiple
sclerosis [Grigoriadis et al., 2015]), uncontrolled inflammation
becomes pathological. One of the critical steps in mounting an
effective inflammatory response is the recruitment of various
leukocytes to the site of inflammation, and thus, this represents
an attractive therapeutic target to reduce untoward inflammation (Muller, 2016a,b).
Leukocyte recruitment involves a complex cascade of sequential adhesive and signaling steps that culminate in the migration of the leukocyte across the vascular endothelium
through a process commonly referred to as diapedesis or
transendothelial cell migration (TEM; Gerhardt and Ley, 2015;
Muller, 2016b). The process requires coordinated movements of
plasmalemmal and vesicular membrane, rapid and reversible
changes in composition of adhesion molecules at junctional
contacts, and local rearrangements of cytoskeletal elements. The
lateral border recycling compartment (LBRC) of endothelial cells
solves many of these problems. The LBRC is a subjunctional

reticulum of interconnected tubulovesicular membrane that
constitutively cycles to and from the endothelial cell border with
a half-time of ∼10 min (Mamdouh et al., 2003). During TEM,
membrane from the LBRC is targeted to the site of TEM along
microtubules (Mamdouh et al., 2008) by Kinesin-1/KLC1c molecular motors (Cyrus and Muller, 2016), bringing increased
membrane surface area containing platelet endothelial cell adhesion molecule (PECAM), poliovirus receptor, CD99, and other
positive regulators of TEM (Muller, 2011; Sullivan et al., 2013;
Sullivan and Muller, 2014) while displacing structural elements
of the junctions such as vascular endothelial cadherin (VE-cadherin; Gonzalez et al., 2016) and Claudin-5 (Winger et al., 2014).
Our laboratory demonstrated that endothelial cell PECAM and
CD99 regulate TEM using distinct signaling pathways to recruit
the LBRC (Watson et al., 2015; Weber et al., 2015). Recruitment
of the LBRC seems to be the final common pathway for TEM;
anything that interferes with the targeted recruitment of
the LBRC to the leukocyte blocks TEM and reduces inflammation (Mamdouh et al., 2008; Dasgupta et al., 2009; Watson
et al., 2015; Weber et al., 2015; Gonzalez et al., 2016). Yet,
how the endothelial cell coordinates transmembrane signaling,
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cytoskeletal rearrangements, and membrane movements to facilitate leukocyte infiltration remains a mystery.
Because the LBRC plays such a pivotal role in TEM, we isolated the compartment and characterized its protein components to gain insight into its regulation (Sullivan et al., 2014).
The LBRC contains a representative sample of membrane proteins present at the lateral border of the endothelial cells (Feng
et al., 2015). However, a cytosolic protein, IQ-motif–containing
GTPase activating protein 1 (IQGAP1) was one of the few proteins enriched in membrane fractions containing the LBRC
(Sullivan et al., 2014), leading us to examine if this protein plays
a role in regulating either the structure or function of the LBRC.
IQGAP1 is a large multidomain cytosolic scaffolding protein
that is involved in numerous seemingly disparate processes,
including angiogenesis, cell proliferation, migration, adhesion,
and tumorigenesis (reviewed in Abel et al., 2015; Hedman et al.,
2015). Consistent with a role in these diverse processes, IQGAP1
has been shown to interact with well over 100 different signaling and cytoskeletal proteins (White et al., 2012; Hedman
et al., 2015). The microtubule-binding proteins CLIP-170 and
EB1, which bind IQGAP1 through its RasGAP C-terminal domain
(Watanabe et al., 2004; Tian et al., 2014; Cao et al., 2015), are of
particular interest in the context of TEM, since microtubules are
critical for targeted recycling of the LBRC (Mamdouh et al.,
2008; Cyrus and Muller, 2016). Furthermore, IQGAP1 homodimerization is believed to be important for its function
(Bashour et al., 1997; Fukata et al., 1997; Mateer et al., 2002; Ren
et al., 2005), at least under some conditions.
Despite numerous studies showing that IQGAP1 acts to coordinate multiple biological processes, its function as part of the
LBRC is not known. There is only a single publication reporting a
diminution in lymphocyte TEM in vitro when IQGAP1 was
knocked down in endothelial cells. However, the mechanism for
this phenomenon was, in retrospect, partially mischaracterized
(Nakhaei-Nejad et al., 2010). Based on its association with the
LBRC, we suspected that IQGAP1 may be a key molecule regulating TEM. The findings presented here show that IQGAP1 is
required for targeted recycling of the LBRC during monocyte
TEM. Furthermore, we show that the actin-binding calponin
homology (CH) domain and the IQ domain must be on the same
IQGAP1 molecule in order to function during TEM, but surprisingly, the microtubule-associating RasGAP C-terminal domain is not required. Most importantly, using bone marrow
chimeras, we provide the first demonstration of the requirement
for endothelial cell IQGAP1 in vivo in two models of inflammation, including intravital imaging in the cremaster muscle.

Results
IQGAP1 in the endothelial cell is required for TEM
We identified IQGAP1 in a screen for LBRC interacting proteins
suggesting that it could play a role in the structure and/or
function of the LBRC (Sullivan et al., 2014). To investigate this
further, we examined the subcellular localization of IQGAP1 in
primary endothelial cells (HUVECs) using immunofluorescence
(Fig. 1 A). As shown previously, IQGAP1 is partially localized to
the cytoplasm but is also prominent at endothelial cell–cell
Sullivan et al.
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Figure 1. IQGAP1 knockdown in endothelial cells reduces monocyte
TEM. (A) HUVECs were fixed, permeabilized, stained for IQGAP1 and PECAM,
and visualized using widefield fluorescence microscopy. Merged panel shows
IQGAP1 in green and PECAM in red. Yellow indicates colocalization. Scale bar
represents 50 µm. (B) HUVECs were transduced with the indicated shRNAs
against IQGAP1 or control shRNA (Cont; scrambled). 3 d after the transduction, the cells were lysed and their protein content resolved using SDS-PAGE
and probed using Western blotting. Actin is shown as a loading control. MW,
molecular weight. (C) HUVECs treated as in B. visualized using immunofluorescence as in A. Both images were collected under the same settings in the
same experiment and processed identically. Scale bar represents 50 µm.
(D) The transmigration of monocytes across HUVECs grown on collagen gels
transduced with IQGAP1 shRNAs or control as detailed in B. The mouse antihuman PECAM antibody hec7 was included as a control. Data represent the
average and standard deviation of three independent experiments, each of
which was comprised of at least three samples and >100 leukocytes scored
per sample for each condition. *, P < 0.01.

contacts along with PECAM (Nakhaei-Nejad et al., 2010; Sullivan
et al., 2014; Tian et al., 2016). To examine IQGAP1 function in
endothelial cells, we designed two knockdown shRNA constructs
targeting its 39 untranslated region (UTR; Table 1). Disruption of
IQGAP1 expression using adenoviral transduction of these
Journal of Experimental Medicine
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Table 1. Primers used in this study
Primer name

Primer sequence (59–39)

IQGAP1 shRNA KD1 39UTR nt649 forwarda
IQGAP1 shRNA KD1 39 UTR nt649

reversea

IQGAP1 shRNA KD2 39UTR nt576 forwarda
IQGAP1 shRNA KD2 39 UTR nt576

reversea

ACCAGGAGTTACACAAACAGAATTGCCTTTTTTGAATTCTCGACCTCGAGACAAATGGCAG
ACCTGGAGTTACACAAACAGAATTGCCCCCGGTGTTTCGTCCTTTCCACAAGATATATAAAGC
ACCACTTCCTTTGAACATGACTGTCACTTTTTTGAATTCTCGACCTCGAGACAAATGGCAG
ACCTCTTCCTTTGAACATGACTGTCACCCCGGTGTTTCGTCCTTTCCACAAGATATATAAAGC

IQGAP1 mRNA amp forward

ATGTCCGCCGCAGACGA

IQGAP1 mRNA amp reverse

TTACTTCCCGTAGAACTTTTTGTT

IQGAP1 nt1 SalI Kozak forward

GCACGTCGACGCCACCATGTCCGCCGCAGACGA

IQGAP1 nt493 SalI Kozak forward

GCACGTCGACGCCACCATGGCCCCTCAGATTCAAGACCTATATG

IQGAP1 nt2190 XmaI reverse no stop

TCTCCCCGGGTGATAGAACTCTGGATCTCCTCCC

IQGAP1 nt2850 XmaI reverse no stop

TCTCCCCGGGACATCATCATAATATCAGACAACTGTTC

IQGAP1 nt4791 XmaI reverse no stop

TCAGCCCGGGACTTCCCGTAGAACTTTTTGTTG

IQGAP1 nt2188 Sal1 Kozak forward

GCACGTCGACGCCACCATGTCTGGGGTGACTGCCGCATATAACC
a

IQGAP1 nt2590 iqmot4 del forward

CCTCCTATGGTTGTGGTCCGAAAATTTGTCC

IQGAP1 nt2253 iqmot1 del reversea

CCTGGTGATCAGGCCTTCATTGGCC

forwarda

GAGGATTTTAGCCATTGGTTTGATTAATGAAGCCCTGGATGAAG

PacI silent mutation reversea

CTTCATCCAGGGCTTCATTAATCAAACCAATGGCTAAAATCCTC

PacI silent mutation

aThese

primers also contained a 59 phosphate.

constructs in primary endothelial cells (HUVECs) reduced IQGAP1 protein levels by ∼90% (Fig. 1 B). Interestingly, the residual IQGAP1 was still observed at both the junction and in the
cytoplasm and appeared proportionately decreased from both
(Fig. 1 C). We examined monocyte TEM using a standard TEM
assay in which primary human peripheral blood mononuclear
cells (PBMCs) are allowed to migrate across cytokine-activated
endothelial cells grown on collagen matrices. This assay examines the behavior of monocytes. Lymphocytes do not migrate
under these conditions (Muller and Weigl, 1992). 78 ± 2% of
monocytes were able to transmigrate across endothelial cells
transduced with scrambled shRNA (Fig. 1 D). However, when
endothelial cells were transduced with IQGAP1 shRNA, TEM was
reduced to 38 ± 4%, a level that is close to the blockade observed
when PECAM homophilic interactions are disrupted with the
mouse anti-human PECAM antibody hec7. The combination of
anti-PECAM antibody and IQGAP1 knockdown was not additive
(Fig. 1 D).
IQGAP1 is required for directing the LBRC to the site of TEM
We showed previously that during TEM the endothelial cell
delivers membrane of the LBRC to the migrating leukocyte and
that this targeted delivery (which we refer to as targeted recycling) is crucial to the process. Given the association of IQGAP1
with the LBRC, we wanted to examine the effect of knockdown
of IQGAP1 expression on the structure and function of the LBRC.
Immunochemical fractionation studies (Feng et al., 2015) demonstrated that the size of the LBRC was not changed in IQGAP1
knockdown cells (Fig. 2). We next performed the standard targeted recycling assay (Mamdouh et al., 2003, 2008, 2009; see
Materials and methods) in which recycling LBRC membrane is
Sullivan et al.
IQGAP1 in transendothelial migration

detected as an enrichment of fluorescence (typically >2× that of
adjacent uninvolved junction) around transmigrating leukocytes
caught in the act of TEM (Fig. 3 A). Note that a “gap” of VEcadherin expression is present at the site of TEM, as expected
(Shaw et al., 2001), where targeted recycling of LBRC occurs
(Gonzalez et al., 2016), as previously published. After allowing
TEM to proceed for 10 min, the majority (∼90%) of adherent
monocytes were found at endothelial cell borders in both control
and IQGAP1 knockdown endothelial cells. On control endothelial
cells, 31 ± 5% of adherent monocytes have extended pseudopods
into the junction and have enriched fluorescence signal indicating targeted recycling of the LBRC (Fig. 3 B). By contrast, only
5 ± 3% of IQGAP1-depleted endothelial cells had increased LBRC
fluorescence adjacent to infiltrating monocytes. (Note that virtually all monocytes in the act of TEM on control endothelial
cells showed LBRC enrichment. Only ∼30% were in the act of
TEM at the time the assay was stopped.) Because there was no
effect on monocyte adhesion or their migration to the cell borders, these findings suggest that IQGAP1 plays an important role
specifically in directing the LBRC to the site of TEM.
PECAM cross-linking recruits IQGAP1
We next wanted to examine the localization of IQGAP1 during
TEM. PBMCs were allowed to migrate across endothelial cells for
10 min and then fixed to arrest them in the various stages of
TEM. These samples were stained for IQGAP1 and examined
using immunofluorescence microscopy to determine where
endothelial cell IQGAP1 is localized during TEM (Fig. 4 A). In
these assays, however, the intense IQGAP1 fluorescence detected
in the migrating monocyte overshadowed that of endothelial
IQGAP1, making it impossible to accurately determine if
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20190008

2584

Figure 2. The amount of PECAM protected in the LBRC at
4°C is not affected by IQGAP1 knockdown. (A) HUVECs
were chilled to 4°C and incubated with the monoclonal antiPECAM antibody hec7 for the indicated time before being
washed extensively and lysed. Lysates were incubated with
recombinant Protein-G agarose beads to recover the surface
PECAM that had been exposed and was bound to antibody
(PECAM IP). PECAM that was not bound at 4°C (which had
either not had time to bind PECAM or was protected in the
LBRC) was recovered in the flow through (FT). The amount of
PECAM in the various fractions was analyzed using Western
blotting for PECAM (PECAM relative mobility, 135 kD; all blots
in this figure are for PECAM). Equivalent amounts of each
sample were loaded to allow for direct comparison of signal
intensity for each time point (i.e., the amount of PECAM recovered in the immunoprecipitate (IP) corresponds directly to
the amount reduced in the FT). The time course shows that
the accessible surface pool of PECAM is quickly bound and
saturated at 4°C. MW, molecular weight. (B) Control and
IQGAP1 knockdown HUVECs were incubated with the antiPECAM antibody hec7 at 4°C for 2 h as in A. After extensive
washing and lysis, surface PECAM that was able to bind hec7
was recovered using Protein-G beads. To make sure the hec7bound PECAM was fully recovered, the supernatant from the
first IP was transferred to tubes with fresh Protein-G beads.
This was repeated three total times (additional empty beads
1–3) before recovering the remaining LBRC-protected PECAM
with additional Protein-G beads and hec7 (last lane, IP −
beads + fresh antibody [aB]). The remaining FT was checked
to make sure that all of the PECAM in the sample was recovered in the IPs (not shown). Equivalent amounts of each
sample were loaded to allow for direct comparison of signal intensity. (C) The amount of PECAM recovered in each IP was quantified using densitometry. The
amount that was protected from antibody at 4°C was calculated by dividing the amount recovered in the last IP by the total amount recovered in all IPs.
Knockdown of IQGAP1 had no effect on the amount of PECAM that was protected at 4°C. The result was the same when calculated using the lysate (first lane)
for the total amount of PECAM. Data shown are representative of three independent experiments, and error bars denote the standard deviation. (D) Because
recently internalized (e.g., in endosomes) and intracellular (e.g., newly synthesized, but not yet trafficked to the surface) PECAM would be indistinguishable
from LBRC-protected PECAM in the assays detailed in A–C, the amount of PECAM on the surface and the LBRC was examined for control and IQGAP1
knockdown HUVECs. Confluent monolayers were incubated for 15 min at 37°C with hec7 to label total plasma membrane PECAM (surface and LBRC). Cells
were washed extensively to remove unbound antibody, lysed, and incubated with Protein-G beads to recover antibody-bound PECAM. The relatively small
amount of PECAM left in the FT suggests that ablation of IQGAP1 does not alter the expression or intracellular distribution of PECAM.

endothelial cell IQGAP1 is recruited to the TEM pore. To examine
this in another way, we incubated endothelial cells with antiPECAM antibody–coated beads. When these beads settle on
endothelial cells, they replicate some of the signals that a leukocyte would deliver by cross-linking and/or clustering some of
the proteins involved in TEM and, in doing so, trigger the recruitment of downstream signaling molecules (van Buul et al.,
2007; van Rijssel et al., 2012; Sullivan et al., 2013; Watson et al.,
2015; Weber et al., 2015). Endothelial cells were incubated with
beads coated with either nonspecific mouse IgG or anti-PECAM,
anti-MHC class I, or anti-ICAM-1 antibodies and stained for IQGAP1. The signal intensity of the IQGAP1 fluorescence adjacent to
the bead was then compared with the intensity in nearby regions. Only ∼20% of beads coated with nonspecific or anti-MHC
class I antibody induced an increase of >1.5 fold in IQGAP1 fluorescence adjacent to sites of adhesion (Fig. 4, B and C). By
contrast, endothelial IQGAP1 fluorescence was enriched at 66 ±
12% sites where anti-PECAM–coated beads adhered to cells. The
IQGAP1 signal seen around anti-PECAM beads clearly extended
beyond the region of contact with the bead, making it unlikely to
be an optical artifact. Similar recruitment was seen with beads
coated with antibodies against poliovirus receptor (data not
Sullivan et al.
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shown), which functions immediately downstream of PECAM in
TEM (Sullivan et al., 2013). As a positive control, we also examined IQGAP1 recruitment to anti-ICAM-1–coated beads. As
expected, ICAM-1 engagement was able to recruit IQGAP1,
which is likely due to the ICAM-1–meditated recruitment of EB1
and cortactin (Schnoor et al., 2011; Tian et al., 2014). Taken together with the previous findings, these data suggest that endothelial cell IQGAP1 is directed to the migrating leukocyte in a
PECAM-dependent manner and, either directly or indirectly,
recruits the LBRC.
The actin-binding domain of IQGAP1 is required for its
junctional localization
IQGAP1 interacts with different classes of molecules through one
of six defined domains (Fig. 5 A). To determine which domains
of IQGAP1 are necessary and sufficient for its role in TEM, we
designed a series of IQGAP1 truncation mutants for expression
in control and IQGAP1-depleted cells. These constructs were
engineered with a C-terminal GFP tag and designed to start and/
or stop between adjacent well-characterized conserved IQGAP1
domains as previously identified (Briggs and Sacks, 2003b; Fig. 5
A and Tables 1 and 2). The subsequent in vitro experiments were
Journal of Experimental Medicine
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Figure 3. IQGAP1 is required for the targeted recycling of the LBRC. (A) HUVECs grown on collagen gels and transduced with control or shRNA against
IQGAP1 (knockdown, KD) as in Fig. 1 were subjected to the targeted recycling assay (described in Materials and methods), which follows the directed
movement of LRBC to the site of transmigration. When visualized using immunofluorescence microscopy, recycled LBRC is observed as increased fluorescence
adjacent to monocytes (visualized with anti-CD18). Staining of the same monolayers for VE-cadherin shows the expected gap in fluorescence where TEM is
proceeding (denoted by the arrows). Images shown were contrast adjusted identically and are representative of three independent experiments.
(B) Quantification of the monocyte position and LBRC recruitment shown in A. Monocytes were considered to be on the endothelial cell (EC) junction if they
overlapped at all with the junction. Data shown are the average and standard deviation of three independent experiments, with at least 50 monocytes scored
per experiment. Data from each experiment were normalized to the total adherent cells to account for subtle differences in adhesion on each monolayer. Scale
bar represents 20 µm. Note that this is a snapshot of a short time point, so only approximately one third of adherent monocytes on control monolayers are
actively transmigrating at this time. *, P < 0.01.

performed using immortalized HUVECs (iHUVECs), which can
be transduced more reproducibly than HUVECs. Whenever
examined, iHUVECs behaved identically to primary HUVECs
with regard to TEM and LBRC function (Yang et al., 2005;
Sullivan et al., 2014; Feng et al., 2015; Watson et al., 2015). All
truncation constructs were detected at their predicted apparent
molecular weights (Fig. 5 B). Note that the IQGAP1 shRNA
construct was designed against the 39 UTR of IQGAP1 and only
targets the endogenous IQGAP1. When examined using fluorescence microscopy, the full-length (FL) construct was observed partially localized to the junction and partially in the
cytoplasm (Fig. 5 C), similar to the distribution of endogenous
IQGAP1 (Fig. 1). As a control, we expressed GFP alone, which
was observed in the cytoplasm and the nucleus. Only the GFP
control was observed in the nucleus, perhaps because it is small
Sullivan et al.
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enough to passively diffuse through the nuclear pore complex.
Of the various IQGAP1 constructs, deletion of the IQ, GRD, and
RasGAP C-terminal domains (constructs Δ5,6 and Δ4-6) did not
noticeably change the localization or the amount of the construct colocalizing with PECAM (Fig. 5 C). Careful analysis and
quantitation of the fluorescence intensity of PECAM, VEcadherin, and the various constructs at the perijunctional region in a number of separate cells showed that PECAM and
VE-cadherin distribution were largely unaffected by IQGAP1
knockdown and construct reexpression (Fig. 6). In addition,
knockdown of IQGAP1 and reexpression of these constructs did
not change the distribution of CD99, ICAM-1, actin filaments, or
microtubules (Figs. S1, S2, S3, S4, and S5). However, constructs
that lacked the N-terminal actin-binding CH domain (constructs Δ1 and Δ1,5,6), were not observed at the junction,
Journal of Experimental Medicine
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Figure 4. IQGAP1 is recruited to anti-PECAM–coated beads. (A) HUVECs were incubated with PBMCs for 10 min before being fixed, stained for IQGAP1 and
PECAM, and visualized using immunofluorescence microscopy. Deconvolved images shown are slices from a z-series of a monocyte in the act of TEM and show
the monocyte (arrowhead in each slice) cell body above the monolayer, in the middle of a transmigration pore, and its pseudopod below the monolayer. Arrows
point to endothelial cell borders. Scale bar represents 25 µm. Bottom panels show the yz orthogonal view along the dashed line displayed in the “Below” panel.
The thin dotted line indicates the surface of the endothelium. (B) HUVECs were incubated with beads coated with nonspecific mouse IgG (mIgG) or mouse antihuman MHC (α-MHC), ICAM-1 (α-ICAM-1), or PECAM (α-PECAM) antibodies for 20 min and then fixed, stained for IQGAP1 (red) and junctions (anti-VEcadherin, green), and visualized using differential interference contrast (left column) and confocal immunofluorescence (right column). Arrowheads denote
beads displaying IQGAP1 enrichment. Scale bar represents 25 µm. (C) Quantitation of the data shown in B. A bead was considered to have enriched IQGAP1 if
the adjacent fluorescence signal was at least 1.5-fold higher than the nearby off-bead signal. Data shown are the average and standard deviation from three
experiments, with >100 beads quantified per experiment per condition. *, P < 0.05 relative to mIgG control. Representative images are shown.

indicating that the CH domain is required for localization to the
junctions.
The actin-binding domain and IQ motifs facilitate TEM
We next sought to determine which of these constructs could
rescue the defect in TEM caused by the knockdown of endogenous IQGAP1. Monocytes were allowed to transmigrate across
cytokine-activated control and IQGAP1 knockdown iHUVECs
expressing the GFP-tagged truncation constructs after which the
samples were fixed and TEM quantified. As with primary endothelial cells (Fig. 1 A), in control iHUVECs (control shRNA,
reexpression construct encoding GFP alone), roughly 80% of
the monocytes were able to undergo transmigration (Fig. 7 A).
This is in contrast to IQGAP1-depleted cells (IQGAP1 shRNA,
Sullivan et al.
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expressing GFP), which supported <40% TEM. This defect could
be rescued entirely by the expression of the FL construct and the
Δ5,6 construct, from which the GRD and RasGAP domains are
deleted. However, constructs lacking either the actin-binding
CH domain (constructs Δ1 and Δ1,5,6) or the IQ domain (construct Δ4-6) were unable to rescue TEM. Note, however, that
they did not have a dominant negative function in cells containing endogenous IQGAP1 (black bars). The same requirements for domains 1 and 4 were found for TEM of neutrophils
(Fig. 7 B). Since the CH domain was involved in targeting IQGAP1
to the junctions, this result indicates that there is an additional
role for the IQ-motifs domain specifically in TEM.
To see if this was due, in part, to changes in the inherent
function of the endothelial junctions in the transduced cells, we
Journal of Experimental Medicine
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Figure 5. The actin-binding domain of IQGAP1 is required for its localization to endothelial cell junctions. (A) Schematic showing the naming of the
various domains of IQGAP1 and the truncations used in this study. GRD, RasGAP-related domain; IQ, IQ motifs; RGCT, RasGAP C-terminus; WW, tandem
tryptophan-containing domain. (B) The GFP-tagged constructs shown in A. were transduced into control (cont) or IQGAP1 shRNA (knockdown, KD) iHUVECs
grown on collagen gels. After 2 d of reexpression of the truncation constructs (which corresponds to 3 d of transduction of the control/KD constructs), the cells
were lysed and their protein content resolved with SDS-PAGE and probed using Western blotting. The blot shown has been probed for IQGAP1 using a
polyclonal antibody against the coiled-coil domain, which is present in all constructs. Arrow denotes the relative mobility of endogenous IQGAP1. MW,
molecular weight. (C) Immunofluorescence images of GFP IQGAP1 constructs transduced in iHUVECs as in B. The images shown were collected in the green
channel using the same settings and processed identically. Arrows denote observed junctional localization of the indicated construct. The images shown are
representative more than three independent experiments. Scale bar represents 50 µm.

subjected the various knockdown and rescue endothelial cells to
a standard permeability assay (Winger et al., 2014). iHUVECs
transduced as described above were incubated with low-molecular-weight rhodamine-dextran (10 kD) for 1 h in the presence of TNFα, after which the amount that passively diffused
across the endothelial cells was quantified (Fig. 7 C). Compared
with control, iHUVECs treated with the inflammatory stimulus
TNFα were modestly more permeable. However, none of the
constructs (knockdown, control, or truncation) had an appreciable effect either way on the permeability of the endothelial
monolayers. These results suggest that domain 4 of IQGAP1 is
required for its function in TEM. We also examined the vascular
integrity in vivo; however, there was no detectable difference in
Sullivan et al.
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in vascular permeability between WT and IQGAP−/− animals as
measured using the Miles assay (Schulte et al., 2011; Radu and
Chernoff, 2013; Fig. 7 D).
The actin-binding domain and IQ motifs of IQGAP1 must be on
the same molecule to facilitate TEM
Although the Δ4-6 construct is observed at the junction suggesting that the polypeptide is not substantially misformed, the
inability of the Δ4-6 construct to rescue the knockdown of IQGAP1 could be due to misfolding of the protein fragment. To
examine this possibility, we designed a construct with the internal deletion of domain 4 (construct Δ4), which lacks only the
four IQ motifs and expressed it in IQGAP1 knockdown
Journal of Experimental Medicine
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Table 2. Primer pairs used for generating the IQGAP1 truncation
constructs
Construct
name

Forward primer

Reverse primer

FL

IQGAP1 nt1 SalI Kozak
forward

IQGAP1 nt4791 XmaI reverse
no stop

Δ5,6

IQGAP1 nt1 SalI Kozak
forward

IQGAP1 nt2850 XmaI reverse
no stop

Δ4-6

IQGAP1 nt1 SalI Kozak
forward

IQGAP1 nt2190 XmaI reverse
no stop

Δ1

IQGAP1 nt493 SalI Kozak
forward

IQGAP1 nt4791 XmaI reverse
no stop

Δ1,5,6

IQGAP1 nt493 SalI Kozak
forward

IQGAP1 nt2850 XmaI reverse
no stop

Δ1-3

IQGAP1 nt2188 Sal1 Kozak
forward

IQGAP1 nt4791 XmaI reverse
no stop

Δ4

IQGAP1 nt2590 iqmot4 del
forward

IQGAP1 nt2253 iqmot1 del
reverse

endothelial cells (Fig. 8, A and B). This construct had the same
junctional and cytoplasmic distribution as endogenous and the
FL IQGAP1-GFP construct (compare Fig. 8 C to Figs. 5 C and 1 A)
suggesting that the construct was expressed and properly localized. However, it was unable to rescue the TEM of monocytes
on IQGAP1 knockdown cells (Fig. 8 D), further confirming the
requirement of the IQ domain for IQGAP1’s function in TEM.
Homodimerization of IQGAP1 has been reported to be important for its function (Bashour et al., 1997; Fukata et al., 1997;
Mateer et al., 2002), which has implications for its mechanism
of action. For example, oligomerization of IQGAP1 has been
shown to be necessary for increasing activation of Cdc42 (Ren
et al., 2005). Therefore, we examined whether the localization
and function of IQGAP1 in TEM required domains 1 and 4 to be
on the same monomer. Additional truncation constructs were
made as before but with mCherry instead of GFP, which allowed
for identification of the various constructs when coexpressed
with the corresponding GFP constructs and visualized using
immunofluorescence. These constructs were transduced in IQGAP1 knockdown endothelial cells along with the indicated GFP
constructs (Fig. 8 B). None of the constructs had a dominantnegative effect, as no disruption of TEM or endogenous IQGAP1
localization was observed (data not shown) in control (no
knockdown) monolayers. As before, constructs that contained
domain 1 were observed at least partially at endothelial cell
junctions, whereas those without (construct Δ1-3-mCherry and
Δ1-GFP) did not colocalize with VE-cadherin at the junction
(Fig. 8 C). Interestingly, neither the coexpression of Δ1-GFP with
Δ4-6-mCherry (which both contain domains 2 and 3) nor Δ4-6GFP with Δ1-3-mCherry (which contain no overlapping domains) was able to rescue the TEM defect caused by IQGAP1
knockdown. Furthermore, in both combinations, constructs that
contained domain 1 were unable to recruit the corresponding
construct lacking domain 1 to the junction. Together, these
findings show that IQGAP1’s function in TEM requires domains
1 and 4 to be on the same molecule.
Sullivan et al.
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IQGAP1 is required for TEM in vivo
We next wanted to extend these studies in vivo but reasoned
the results collected using whole-animal IQGAP1 knockout
could be confounded by the potential function of IQGAP1 in
leukocytes. To simplify the interpretation of these studies,
since a conditional IQGAP1 knockout mouse does not exist, we
used adoptive bone marrow transfer to make chimeras of WT
donors and WT or IQGAP1−/− recipients so that all myelomonocytic cells and their derivatives would be WT, but in the
knockout recipients, the endothelial cells (and other tissues)
would lack IQGAP1 expression. We first examined TEM using
the croton oil dermatitis model of inflammation. For this assay,
croton oil, a potent inflammatory stimulus, or carrier alone,
was topically applied to both leaflets of one ear. After 5 h (to
allow for sufficient recruitment of neutrophils), the animals
were sacrificed and their ears harvested and processed for
whole-mount confocal microscopy (Watson et al., 2015; Weber
et al., 2015; Sullivan et al., 2016). Both chimeras recruited a
similar number of neutrophils to the inflamed tissue. In WT
recipients, the majority of these neutrophils were observed
outside of blood vessels in the inflamed tissue (Fig. 9 A). In
contrast, neutrophils in the IQGAP1−/− recipients were mostly
still inside the venules. Furthermore, we used confocal microscopy to distinguish the precise position of the recruited
neutrophils relative to the endothelium and basement membrane, which we assigned according to a standard scoring
method (Fig. 9 B). We systematically scored the neutrophil
positions in at least five fields from five WT and 6 IQGAP1−/−
recipients. Although there was no difference in the total neutrophil recruitment to the inflamed ears between the two
chimeras (Fig. 9 C), IQGAP1−/− recipients showed a significant
reduction in the number of neutrophils observed outside the
vessel with corresponding increase in the number observed
with a portion of their cell body in the endothelium (“In TEM”;
Fig. 9 D).
Although these findings support a role for IQGAP1 in TEM
in vivo, we wanted confirmation using a second model that also
allowed us to examine the process in live animals. To do this, we
again used bone marrow chimeras as before, except that in these
experiments, the donors expressed GFP under the control of the
LysM promoter, which allows for the visualization of neutrophils using fluorescence intravital microscopy (IVM). These
mice were injected intrascrotally with mouse IL-1β to induce
inflammation and fluorescently conjugated nonblocking antiPECAM antibody to label the vasculature in red to distinguish
it from the green neutrophils (Sullivan et al., 2016). After 4 h,
which allows for a robust inflammatory response, the cremaster
muscle was exteriorized and visualized (Fig. 10 A and Videos
1 and 2). In both WT and IQGAP1−/− recipients, we observed
similar (and typical) rates of neutrophil rolling flux (Fig. 10 B)
and adhesion (Fig. 10 C; Sullivan et al., 2016). Purified human
neutrophils crawling on either WT or IQGAP1−/− endothelium
spent 90–95% of their time associated with a junction (not
shown). However, in IQGAP1−/− recipients, there was a ∼80%
reduction in TEM events compared with WT recipients
(Fig. 10 D; 6 ± 4 events per 300 µm per hour compared to 42 ± 4
events, respectively).
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Figure 6. Quantitation of the junctional localization of the IQGAP1 constructs. iHUVECs were transduced with control shRNA (top row) or knockdown
shRNA (other rows) and the indicated expression constructs as described in Materials and methods and confirmed in Fig. 7. Immunofluorescence images of
PECAM, VE-cadherin, and the indicated IQGAP1 construct were analyzed for the enrichment of each molecule at the junction as described in Materials and
methods. The left column (also shown in Fig. S1) shows a representative image for each of the constructs analyzed. For each junctional analysis, a 20-µm line
was drawn centered on and perpendicular to the junction and the pixel intensity (normalized fluorescence, arbitrary units [AU]) along that line plotted as a
histogram for each of channel separately. The compiled histograms collected from at least three different images and at least two random junctions are shown
in the three right columns for the indicated GFP construct, VE-cadherin, and PECAM, respectively. Although the images were all collected under the same
settings, the individual lines still needed to be adjusted relative to the each other to account for variations in staining intensity (for PECAM and VE-cadherin)
and expression (for the IQGAP1 constructs). Note that this makes the intensities for the construct-GFP plots similar at the distal 0 µm and/or 20 µm ends of the
plot but retains any meaningful differences at the junction in the middle. Only constructs that contained domain 1 (IQGAP1 FL; Δ5,6; and Δ4-6) were significantly enriched at the junction. Dashed white line in the top left panel shows two representative 20-µm lines that were analyzed. Dashed black line in each
compiled histogram shows the midpoint of the 20-µm line plot, which corresponds to the center point of the junction. Scale bar represents 25 µm.
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Figure 7. The actin-binding domain and IQ
motifs of IQGAP1 are required for IQGAP1’s
function in TEM. (A) iHUVECs grown on collagen gels, transduced with the indicated control,
knockdown (KD), and reexpression constructs,
and stimulated with TNFα were incubated with
PBMCs for 1 h, after which the samples were
washed, fixed, stained, and visualized using
bright-field microscopy as described in Materials
and methods. Data shown represent the percentage of monocytes that were found beneath
the endothelial cell (EC) monolayer and are the
average and standard deviation from three experiments, each of which comprised triplicate
samples for each condition. *, P < 0.01 compared
with the knockdown-FL rescue control. (B) The
same experiment as in part A was performed
using purified human neutrophils. Transmigration was allowed to proceed for 15 min.
(C) iHUVEC grown on collagen gels, transduced,
and stimulated as described above. 2 d after the
transduction of the truncation constructs, the
monolayers were treated with rhodaminedextran (molecular weight, 10 kD) for 1 h. After
four quick washes, the fluorescence that had
passed through the monolayer into the collagen
gel was quantified using a fluorescence plate
reader. Data were collected for each sample and
normalized to the average observed with the
GFP control shRNA samples within each experiment. Data shown for A–C are the average and
standard deviation from three independent experiments, each of which contains triplicate
samples for each condition. None of the conditions were statistically different (P < 0.05)
from any other. (D) The Miles assay, measuring
the vascular leakage of Evans Blue, was performed on the ears and dorsal skin of WT and
IQGAP1 knockout mice. No statistical difference
was observed between the two groups. Data
shown are for four mice for each group.

Discussion
IQGAP1 is a scaffolding molecule that coordinates the interactions of >100 proteins involved in dozens of intracellular events
involving the actin and microtubule cytoskeletons, cell polarity,
cell adhesion, organelle trafficking, and cell signaling. In light of
this, it may not come as a surprise that IQGAP1 has a role in
TEM. However, considering the multiple and complex adhesive
interactions, signaling pathways, membrane movements, and
cytoskeletal rearrangements that are involved in the process of
TEM, it is surprising to find a single IQGAP1-dependent mechanism that dominates the process; knockdown of IQGAP1 significantly reduced targeted recycling of the LBRC and therefore
TEM, and both could be restored to control levels by expression
of FL IQGAP1 or a version containing the CH and IQ domains.
There was no effect on the size of the LBRC (Fig. 2), leukocyte
adhesion or locomotion on the endothelial surface (Fig. 3),
endothelial cell permeability (Fig. 7), or distribution of VEcadherin (Fig. 6), PECAM, CD99, ICAM-1, microtubules, or actin filaments (Figs. S1, S2, S3, S4, and S5). We cannot rule out
that there may be other IQGAP1-dependent processes ongoing in
the endothelial cell that contribute to TEM. However, those
Sullivan et al.
IQGAP1 in transendothelial migration

processes would also have to require the CH and IQ domains to
be present on the same molecule.
The data presented here provide the first demonstration that
IQGAP1 is required for the TEM of monocytes and neutrophils,
and, most importantly, show that IQGAP1 is selectively required
for the diapedesis step of inflammation in vivo. There was no
effect on leukocyte rolling flux, adhesion, or neutrophil crawling
time (Fig. 10 and Videos 1 and 2). This was a true block in TEM,
not merely a delay. Leukocytes remained blocked for the entire
observation period; in contrast, control leukocytes completed
TEM in a few minutes. Furthermore, we show the mechanism
behind this: IQGAP1 is required for efficient delivery of the LBRC
to migrating monocytes. Targeted recycling was significantly
attenuated in IQGAP1 knockdown endothelial cells. As with
other molecules selectively involved in the diapedesis step
(Schenkel et al., 2002; Dasgupta et al., 2009; Mamdouh et al.,
2009; Cyrus and Muller, 2016), leukocytes show no defect in
their ability to bind to endothelial cells lacking IQGAP1 or their
ability to migrate to cell junctions either in vitro or in vivo. In
this regard, IQGAP1 is required for efficient TEM but does not
activate it or appear to control a rate-limiting step. Expression of
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https://doi.org/10.1084/jem.20190008

2591

Figure 8. The actin-binding domain and IQ motifs of IQGAP1 must be on the same molecule for IQGAP1 to function. (A) Schematic showing the naming
of additional IQGAP1 truncation constructs fused to GFP or mCherry. (B) The tagged constructs shown in A were transduced into control or IQGAP1 shRNA (KD)
iHUVECs grown on collagen gels as indicated (“GFP” denotes monolayers expressing GFP alone). After 2 d of reexpression of the truncation constructs (which
corresponds to 3 d of transduction of the control/KD constructs), the cells were lysed and their proteins resolved with SDS-PAGE and probed using Western
blotting. The representative Western blots shown were probed for IQGAP1, mCherry, and actin using the indicated antibodies. Blots shown are from different
gels/transfers of the same samples. Note that mCherry construct IQGAP1Δ1-3 (Δ1-3 in red) is not detected with the IQGAP1 antibody because it lacks the
coiled-coil domain that is recognized by the antibody. Arrow denotes the relative mobility of endogenous IQGAP1. (C) Immunofluorescence images of the
mCherry and GFP IQGAP1 constructs transduced in iHUVECs as in B. For each channel, the images shown were collected with the same settings and processed
identically to preserve relative intensity differences. Arrowheads denote observed junctional localization of the indicated construct. The images shown are
representative of more than three independent experiments. Scale bar represents 25 µm. (D) iHUVECs grown on collagen gels were transduced with the
indicated constructs and subjected to the standard TEM assay (as described in Fig. 7 and the Materials and methods). The percent TEM is shown for the
indicated IQGAP1 KD coexpression combinations along with control samples (black bars); no-knockdown expressing GFP alone and no-knockdown but TEM
blocked with the function-blocking anti-PECAM antibody hec7 (α-PECAM). Data shown are the average and standard deviation from three experiments, each of
which comprised triplicate samples for each condition. *, P < 0.01 compared with the knockdown-FL rescue control.

FL IQGAP1 or constructs containing the “minimal motif” in endothelial cells that already contain endogenous IQGAP1 do not
increase the rate or extent of TEM (Fig. 7 A). Furthermore,
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constructs lacking domain 1 or 4 do not act as dominant negatives when expressed in endothelial cells with a normal complement of IQGAP1 (Fig. 7 A).
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Figure 9. IQGAP1 is required for neutrophil
TEM in vivo. (A) IQGAP1 knockout and WT mice
were lethally irradiated and their bone marrow
reconstituted from WT donors as described in
Materials and methods. After allowing reconstitution of the mice, one ear of each mouse was
treated topically with croton oil in an acetone/
olive oil carrier while the other ear received the
carrier only. After 5 h, the mice were sacrificed
and their ears processed for immunofluorescence imaging using confocal microscopy. Representative images from WT (WT BM → WT) and
IQGAP1 knockout (WT BM → IQGAP1−/−) are
shown. Neutrophils were visualized with an antibody against MRP14 (green), the vessel and
junctions were detected using anti-PECAM, and
the basement membrane was visualized using
anti-Collagen IV. Insets show the orthogonal
view at position denoted by the dashed line.
Orthogonal inset 1 shows one leukocyte in TEM
(i), one apical (ii), and one at the basement
membrane (iii). Orthogonal inset 2 shows one
leukocyte on the apical surface (iv) and two that
are in TEM (v and vi). Scale bar represents
50 µm. (B) Schematic of the positional scoring
system used to quantify the neutrophil locations
observed in A. (C) Quantitation of the total
number of neutrophils per field. Only neutrophils
within 50 µm of the vessel were scored. (D)
Quantitation of the leukocyte positions from the
images collected in A. Data shown were collected from two separate experiments, each of
which contained at least two mice per condition.
At least five fields (corresponding to ≥100 neutrophils) for each mouse were analyzed (n = 5 for
WT recipients and n = 6 for the IQGAP1−/− recipients). Data shown are the average of the averages for each mouse and do not include data for the neutrophils
found in the luminal position. *, P < 0.01. Carrier-only ears showed no signs of inflammation; neutrophils were rarely found in the tissue or associated with
vessels (data not shown).

Although IQGAP1 is partially localized to the cell borders and
can interact with both actin filaments and microtubules, the role
of IQAGP1 in TEM does not appear to be related to effects on
junctional integrity. We found no effect of IQGAP1 knockdown
on endothelial cell monolayer permeability in vitro (Fig. 7 C) or
in vivo in IQGAP1 knockout animals (Fig. 7 D). It is now quite
evident that leukocyte TEM and monolayer permeability are
molecularly distinct phenomena (Schnoor et al., 2011; Wessel
et al., 2014; reviewed in Vestweber et al., 2014; Muller, 2016a).
We originally identified IQGAP1 as a molecule enriched in
isolated LBRC membrane fractions (Sullivan et al., 2014). However, we have not been able to coimmunoprecipitate IQGAP1
along with PECAM, suggesting that although both are critical for
initiating TEM, their strong interaction is not required. Similarly, LBRC is trafficked along microtubules toward the plus end
during TEM; however, we could not coimmunoprecipitate IQGAP1 with the microtubule plus-end–binding protein EB1 (not
shown), and the function of IQGAP1 in TEM does not require the
microtubule-interacting RasGAP C-terminal domain (Figs. 7 and
8). Furthermore, knockdown of IQGAP1 does not affect the expression or distribution of PECAM, VE-cadherin, CD99, ICAM-1,
actin, or microtubules (Figs. 6, S1, S2, S3, S4, and S5).
The results reported here substantially extend our understanding of the role of IQGAP1 in TEM, which was previously
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observed in only a single in vitro model using lymphocytes
(Nakhaei-Nejad et al., 2010). In that report, knockdown of IQGAP1 in HUVECs by siRNA was associated with a modest (30%)
decrease in transmigration of lymphocytes (Nakhaei-Nejad
et al., 2010) without a change in lymphocyte adhesion or migration to junctions, similar to what we found. As we had
originally reported (Mamdouh et al., 2008), they also found that
disruption of microtubules under conditions that did not perturb actin assembly or disrupt adherens junctions also inhibited
TEM (Nakhaei-Nejad et al., 2010). Since IQGAP1 had been shown
to interact with microtubules, and since siRNA inhibition of
IQGAP1 and dissolution of microtubules produced the same
phenotype, these authors concluded that the effect of IQGAP1
knockdown on TEM involved microtubule dynamics. However,
that conclusion turned out to be incorrect. Intact microtubules
are indeed required for TEM. They serve as tracks on which the
LBRC moves (Mamdouh et al., 2008; Cyrus and Muller, 2016). In
fact, knowing the critical role of microtubules in movement of
the LBRC and the known interactions of IQGAP1 with microtubules, we at first thought that the role of IQGAP1 in targeted
recycling of the LBRC would involve interactions with microtubules. We set out to test this hypothesis by rescuing IQGAP1
expression with IQGAP1 molecules missing established interaction domains. However, we found that although microtubules
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Figure 10. IVM confirms a role for endothelial IQGAP1 in neutrophil TEM. (A) WT and IQGAP1 knockout mice were reconstituted with bone marrow from
mice expressing GFP under the control of the LysM promoter (for visualization of GFPhi neutrophils). Inflammation was induced by intrascrotal injection of
IL-1β. Nonblocking fluorescently conjugated anti-PECAM (red) was coinjected with IL-1β to allow for visualization of the vasculature. 4 h after the injection, the
cremaster muscle was exteriorized and prepared for confocal microscopy as described in Materials and methods. The images shown are Z-projections of the
3D stacks collected at the indicated time points. The corresponding FL videos are in the supplemental materials. Time stamp denotes total elapsed time from
the injection of inflammatory stimulus. Arrowheads denote neutrophils that are in the process or have recently undergone TEM. Scale bars represent 50 µm.
(B and C) Quantification of the rolling flux and adhesion, respectively, of neutrophils as determined from the initial recording; the two groups of mice were not
statistically different for these measurements. (D) Quantification of the number of TEM events observed during the longer recording. *, P < 0.01. Error bars
denote standard deviation.

are clearly necessary for targeted movement of the LBRC in TEM
(Mamdouh et al., 2008; Cyrus and Muller, 2016), the RasGAP
C-terminal domain of IQGAP1 that interacts with microtubules is
not required for its role in this process (Figs. 7 and 8). Furthermore, knockdown of IQGAP1 has no effect on the distribution of microtubules in the cell (Fig. S5).
Because IQGAP1 is a multidomain protein with >100 reported
interacting partners, in order to begin to understand its role in
TEM, we wanted to determine which of its domains are involved
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in this function. Using domain truncations, we show that both
the N-terminal CH domain and the IQ domain are required for
TEM (Fig. 7). Furthermore, we show that both the CH and the IQ
domains are required to be on the same IQGAP1 molecule to
support TEM. This suggests that even if the two domains (on
separate polypeptide chains) are brought together via homodimerization, IQGAP1’s function in TEM still cannot be restored.
Alternatively, domains 1 or 4 could themselves be required for
dimerization. To our knowledge, this is not only the first report
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of a function for IQGAP1 that requires both the CH and IQ domains but also the first report that describes the requirement for
two domains of IQGAP1 to be present in the same polypeptide
chain. Numerous proteins have been shown in other systems to
interact with domains 1 and 4 in other cell types and systems.
Which of these possible interacting factors, if any, plays a role in
TEM remains an area for future investigation.
The major interaction reported to be facilitated by the CH
domain is with filamentous actin (reviewed in Nussinov and
Jang, 2014; Abel et al., 2015; Watanabe et al., 2015). Our findings show that the CH domain is involved in targeting IQGAP1 to
the cell cortex (Figs. 5 and 6). This localization in itself may be
required for IQGAP1’s function; i.e., without its CH domain,
IQGAP1 may not be at the correct place to perform its essential
function. Alternatively, IQGAP1 binding to actin may be part of
its function in TEM. Indeed, the actin-bundling protein cortactin
and other actin-binding proteins have been shown to regulate
leukocyte TEM (Schnoor et al., 2011; Schnoor, 2015), and endothelial cell IQGAP1 has, in other systems, been shown to interact
with cortactin (Usatyuk et al., 2009; Tian et al., 2014).
A putative role for the IQ motifs in TEM is more difficult to
deduce, largely because this region has been shown to facilitate
interactions with multiple proteins including myosin essential
light chain, S100B, and calmodulin (Joyal et al., 1997; Weissbach
et al., 1998; Pathmanathan et al., 2008; Malarkannan et al.,
2012). IQGAP1 has four IQ motifs, each of which largely, although not exactly, conforms to the consensus sequence
IQXXXRGXXXR (Bähler and Rhoads, 2002; Caride et al., 2010).
Multiple reports indicate that the IQ motifs can bind apocalmodulin and Ca2+/calmodulin, albeit with varying specificity
(Mateer et al., 2002; Li and Sacks, 2003; Jang et al., 2011).
We and others have shown that calcium signaling is required for TEM (Huang et al., 1993; Su et al., 2000; Weber et al.,
2015). The increase in intracellular free calcium triggered early
in TEM occurs specifically through endothelial PECAM stimulating the activation of the divalent cation channel TRPC6
(Weber et al., 2015), although the downstream players in this
pathway remain unknown. Ca2+/CaM binding to IQGAP1 reduces binding of most of the IQGAP1 binding partners that have
been examined, such as Cdc42, actin, and E-cadherin (Joyal
et al., 1997; Li et al., 1999; Mateer et al., 2002). IQGAP1 is displaced from regions of cell–cell contacts upon global calcium
influx (Mateer et al., 2002). Several reports show that IQGAP1
does not bind actin and Ca2+/calmodulin simultaneously
(Pelikan-Conchaudron et al., 2011; Liu et al., 2016). Targeted
recycling is an iterative process (Watson et al., 2015). Perhaps
IQGAP1 facilitates TEM by binding cortical actin and apocalmodulin in a steady state, primed for action. After an increase in local calcium concentration, the interaction between
IQGAP1 and Ca2+/calmodulin changes and IQGAP1 disassociates
from actin, which could then undergo remodeling based on
other local cues (Briggs and Sacks, 2003a), while the LBRC is
freed to undergo another round to targeted recycling in a Ca2+dependent manner. This model remains to be tested. Clearly,
further work will be required to determine which of these
possible interactions (or others) mediate the function of
IQGAP1 in TEM.
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Materials and methods
Antibodies and proteins
Mouse anti-human PECAM IgG2a (clone hec7; Muller et al.,
1989), mouse anti-human CD99 IgG1 (clone hec2; Schenkel
et al., 2002), mouse anti-human VE-cadherin IgG2a (clone
hec1; Ali et al., 1997), Armenian hamster anti-mouse PECAM
(clone 2H8; Schenkel et al., 2004), anti-ICAM-1 mAb (clone R6.5,
hybridoma obtained from the American Type Culture Collection), mouse IgG2a anti–human MHC I (clone W6/32; Muller
et al., 1989), mouse anti-human ICAM-1 (clone R6.5; Mamdouh
et al., 2009), and mouse anti-human CD18 (clone IB4;
Wright et al., 1983) were produced in the laboratory via hybridoma methodologies (Bogen et al., 1994; Ali et al., 1997). The
nonfunction blocking mouse anti-human PECAM antibody
(clone P1.1; Liao et al., 1997) was purified from ascites generously
gifted from Peter Newman (Blood Center of Wisconsin, Milwaukee, WI) and digested to F(ab) (fragment antigen binding)
fragments according to standard methods. Rabbit polyclonal
anti-human PECAM (177) was produced as previously described
(Muller et al., 1993). Mouse anti-human β actin (for Western
blotting) and mouse anti-human tubulin (catalog number
T6074) were purchased from Millipore Sigma (catalog number
A2228, clone AC-74). Rabbit anti-mouse collagen IV (ab19808),
phalloidin-iFluor 555 (ab176756, for visualizing actin with immunofluorescence microscopy), and rat anti-mouse myeloidrelated protein 14 (MRP14; ab105472, clone 2B10) were
purchased from Abcam. Rat anti-mouse PECAM (clone 390)
was purchased from EMD Millipore. Rabbit anti-human IQGAP1
was purchased from Santa Cruz Biotech (catalog number H-109).
Mouse serum, Armenian hamster serum, rat serum, nonspecific
mouse IgG, goat anti-Armenian hamster IgG, and Dylight 488–
or Dylight 550–goat anti-rabbit and goat anti-mouse secondary
antibodies were purchased from Jackson ImmunoResearch
Laboratories. Rat anti-mouse PECAM, mouse anti-human CD18,
rabbit anti-mouse collagen IV, rat anti-mouse MRP14, and goat
anti-Armenian hamster IgG were directly conjugated with Dylight 488, DyLight 550, or Dylight 649 (Thermo Fisher Scientific), as indicated, according to the manufacturer’s guidelines.
Goat anti-rabbit–HRP and goat anti-mouse–HRP were purchased
from BioRad.
Animals
All protocols involving mice were reviewed and approved by the
Institutional Animal Care and Use Committee at Northwestern
University (Public Health Service assurance number A328301).
Mice were housed in the institutional animal facility operated by
the Center for Comparative Medicine at Northwestern University and maintained according to standard Association for Assessment and Accreditation of Laboratory Animal Care methods.
All experiments in this study used mice between 8 and 12 wk
old. The C57BL/6 LysM-eGFP mouse strain (obtained from Dr.
Paul Kubes, University of Calgary, Calgary, Canada) was described previously (Faust et al., 2000; Sullivan et al., 2016).
Briefly, the myelomonocytic cells of these mice were rendered
fluorescent by the insertion of eGFP in the lysozyme M (LysM)
locus, under control of the LysM promoter. This allows for
visualization of GFPhi neutrophils and GFPlow monocytes/
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macrophages. IQGAP1 knockout mice in the C57BL/6 background were a generous gift from Dr. Asrar Malik (University of
Illinois at Chicago, Chicago, IL) and have been described elsewhere (Li et al., 2000; Urao et al., 2010).
Isolation of endothelial cells and primary human PBMCs
All procedures involving human subjects and human materials
were approved by the Institutional Review Board of Northwestern University Feinberg School of Medicine. HUVECs were
isolated from human umbilical cords as previously described
(Muller et al., 1989; Muller and Luscinskas, 2008). At their
second passage, isolated HUVECs were either cultured on threedimensional (3D) type I collagen matrices (PureCol, Inamed
Biomaterials; described in Muller and Luscinskas, 2008) or
coverslip dishes (for the bead experiments; MatTek) and allowed
to reach confluence before use (typically 2–3 d after seeding) to
ensure the formation of high-quality basement membranes. To
grow endothelial cells that behaved identically for the reexpression experiments, we used a well-characterized procedure to generate a stable iHUVEC line as described previously
(Moses et al., 1999). In our hands as well as in other published
studies, these cells have been shown to grow in stable monolayers, express appropriate levels of the relevant adhesion
molecules, and support TEM similarly to unmodified HUVECs
(Ancuta et al., 2003; Yang et al., 2005; Watson et al., 2015).
PBMCs were harvested as described previously (Muller and
Weigl, 1992; Muller and Luscinskas, 2008).
Cloning of IQGAP1 constructs and adenoviral transduction
shRNA constructs against the 39 UTR of human IQGAP1 (National Center for Biotechnology Information accession no. NM_
003870.3) KD1 59-GGGCAATTCTGTTTGTGTAACTCCAGGTAC
CAGGAGTTACACAAACAGAATTGCCTTTTTT-39 and KD2 59GGTGACAGTCATGTTCAAAGGAAGAGGTACCACTTCCTTTGA
ACATGACTGTCACTTTTTT-39 under the control of the human
U6 promotor were generated using site-directed mutagenesis by
inverse PCR and the primers listed in Table 1 to replace the
hairpin sequence of the nonspecific control pENTR4 vector
(Invitrogen) described in Watson et al. (2015) (sequence 59-ACT
ACCGTTGTTATAGGTGTTCAAGAGACACCTATAACAACGGTA
GTTTTTT-39). The corresponding IQGAP1 and control shRNA
constructs were recombined with pAd/PL-DEST (Invitrogen)
using LR clonase (Invitrogen) according to the manufacturer’s
guidelines. These vectors were then digested with PacI restriction enzyme (Fermentas; Thermo Fisher Scientific) and transfected into 293A cells to generate adenovirus for transduction
according to the manufacturer’s guidelines.
The FL IQGAP1 cDNA was obtained by PCR using human HT29
cell mRNA as a template with forward and reverse primers listed
in Table 1. The PCR product was cloned into the Gateway donor
vector pDONR201 (Invitrogen) as recommended by the manufacturer. The FL IQGAP1 construct was amplified using the primers detailed in Table 1 in the combination detailed in Table 2 and
digested using SalI and XmaI. The resulting product was subcloned into a SalI/XmaI–digested pENTR4-GFP vector (a generous
gift from Jonathan Jones, Northwestern University, Chicago, IL).
The pENTR4-GFP vector was generated by combining the
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backbone of BamH1/NotI digested pENTR4 (Invitrogen) with the
eGFP containing the BglII/NotI fragment of pEGFP-N1 (Clontech).
pENTER4-mCherry was generated in exactly the same way from
pmCherry-N1 (Clontech). To disrupt the internal PacI restriction
site in IQGAP1 (required for subsequent virus production), the
silent mutation A1632G was introduced using the primers indicated in Table 1 and site-directed mutagenesis by inverse PCR.
This FL IQGAP1 construct (referred to here as FL) was used as the
template to generate the IQGAP1 truncation constructs using the
primers and combinations detailed in Tables 1 and 2. All forward
primers were engineered to contain a Kozak sequence and a start
codon; the reverse primers were designed to be in frame and
without a stop codon between IQGAP1 and eGFP. Construct Δ4
(lacking nt 2,254–2,589, the internal deletion of domain 4 of
IQGAP1) was generated using PCR with the primers in Table 2
and the IQGAP1-FL-GFP pENTR vector as a template. The resulting product was then ligated and transformed using standard
methods. All constructs were sequenced to ensure the correct
insertion and fidelity of the subcloning. The resulting C-terminal
GFP-tagged constructs were recombined with the adenoviral
pAd/CMV/V5-DEST vector (Invitrogen). The resulting vectors
were digested with PacI and transfected into 293A cells, which
were then to produce adenovirus according to the manufacturer’s guidelines for transduction of the various constructs.
For adenoviral transduction of iHUVECs, cells were seeded
on supported collagen gels at 10,000 cells/well. The following
day, monolayers were washed three times with conditioned
media and incubated with knockdown or control adenovirus in
100 µl of conditioned media overnight. Monolayers were then
washed as before and incubated with the indicated rescue construct in 100 µl of conditioned media overnight. The media was
then replaced with fresh media for 24 h before the cells were
used in the experiments. With this scheme, the knockdown and
reexpression constructs were transduced for 72 and 48 h, respectively, before the start of each assay. All experiments involving the knockdown (and reexpression, where indicated)
were performed with this timing.
Western blotting
HUVECs or iHUVECs were grown on collagen gels and transduced as indicated and described above. After washing with PBS,
the cells were lysed in 50 µl PBS containing 1% NP-40, 1× protease inhibitor cocktail (P8340; Sigma-Aldrich), and 1 mM PMSF
(Sigma-Aldrich) for 5 min at room temperature (RT). The lysates
were collected and pooled from two or three wells, mixed with
6× Laemmli loading buffer with β-mercaptoethanol, and heated
at 60°C for 30 min. Equivalent amounts were loaded onto a 8%
polyacrylamide gel and resolved using SDS-PAGE. Proteins were
transferred to polyvinylidene difluoride membrane and detected
using standard Western blotting techniques. The amount of virus needed to achieve expression levels for the constructs that
was comparable to endogenous IQGAP1 expression level was
determined empirically for each construct.
Quantification of LBRC size
Immunochemical quantification of LBRC size was performed as
previously described (Feng et al., 2015) using the differential
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accessibility of the LBRC to externally provided antibody at 37°C
vs. 4°C followed by complete immunoprecipitation and quantitative scanning of Western blots.
Permeability assay
For permeability assays, endothelial cells were cultured on collagen gels as described above. Monolayers were washed with
PBS and 100 µg/ml 10-kD rhodamine-Dextran (Sigma-Aldrich)
was added to each well. Monolayers were then incubated at 37°C
in 5% CO2 for 1 h. After 1 h, monolayers were then washed extensively with PBS and the relative fluorescence intensity of
rhodamine-dextran that had passed across the monolayers into
the collagen gels was measured by a FilterMax F5 microplate
reader (Molecular Devices). Indicated results are the mean fluorescence intensity of at least three independent experiments
with at least replicates for each sample.
Immunofluorescence microscopy
Confluent HUVECs or iHUVECs were fixed in 2% paraformaldehyde for 20 min, washed three times with PBS, and blocked
with blocking buffer (PBS with 5% BSA [Fraction V; Thermo
Fisher Scientific] and 1% goat serum) was added for 30 min at
RT. Cells were then incubated with primary antibody at 10 µg/
ml in blocking buffer for 45 min at RT, washed extensively with
PBS, and then incubated with secondary antibody at 4 µg/ml in
blocking buffer for 45 min at RT protected from light. For the
visualization of IQGAP1, cells were permeabilized before
blocking for 4 min with 0.1% Triton X-100 (Sigma-Aldrich).
Confocal images (all figures unless otherwise noted) were collected using an Ultraview VoX imaging system equipped with a
Yokogawa CSU-1 spinning disk. Images were acquired with a
40× oil objective using Volocity software (numerical aperture
[NA] 1.0). Widefield images (specifically Figs. 4 A and 5 C) were
collected using a restoration workstation (DeltaVision 3D; Applied Precision) equipped with an inverted microscope (model
IX70; Olympus) using a 60× oil objective (NA 1.42). Some widefield images (specifically Fig. 4 A) were processed using DeltaVision software and its associated constrained iterative
deconvolution algorithm using a point spread function collected contemporaneously for each channel using standard
fluorescence beads.
Analysis of junctional localization
Images from iHUVECs transduced with either control or IQGAP1
shRNA 1 and expressing the various IQGAP1 rescue constructs
were analyzed to determine the enrichment of the various
proteins at the junction. For each junctional analysis, a 20-µm
line was drawn centered on and perpendicular to the junction
and the pixel intensity along that line was recorded for each of
channel. Suitable junctions were identified for analysis based on
the continuity and intensity of VE-cadherin staining and without regard for the signal in the other channels. Although the
images were all collected under the same settings, the individual
lines still needed to be adjusted relative to the each other to
account for variations in staining intensity (for PECAM and VEcadherin) and expression (for the IQGAP1 constructs). For VEcadherin and PECAM, the histogram plots were normalized to
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the maximum (which was also the midpoint of the junction). For
the IQGAP1 constructs, the plot values were normalized to the
cytoplasmic intensity distal to the junction. Note that this makes
the intensities for the construct plots similar at the distal 0 µm
and/or 20 µm ends of the plot but retains any meaningful differences at the junction in the middle.
Polystyrene bead coating
Polystyrene beads (average diameter, 3 µm) were coated as
described previously (Sullivan et al., 2013; Weber et al., 2015).
For the bead experiments, HUVEC monolayers were grown on
fibronectin-coated coverslip dishes to confluence. The conjugated beads were diluted into preconditioned HUVEC media and
allowed to settle on the cells and bind for 20 min to polystyrene
beads. Monolayers were then washed with PBS, fixed with 4%
paraformaldehyde and the indicated proteins visualized using
confocal immunofluorescence. Images within each experiment
were captured under identical settings and processed identically
using ImageJ software to preserve any differences in relative
intensities. Images were first background corrected by subtracting the background value (determined as the average pixel
intensity in an off cell area) from the raw pixel intensity across
the entire image. Beads were then analyzed using line scanning.
Beads were score positive for enrichment if the IQGAP1 fluorescence intensity adjacent to the bead was ≥1.5-fold higher than
the intensity several microns away from the bead. More than
300 beads were analyzed in three separate experiments were
quantitated.
TEM and LBRC targeted recycling assays
TEM assays were performed on cytokine activated endothelial
cells as previously described (Muller and Luscinskas, 2008).
Imaging was performed with a Zeiss Ultraphot microscope with
Nomarski optics and a SPOT Insight Color CCD (Diagnostic Instruments). TEM was analyzed by manually counting ≥100 cells
per collagen gel and noting their position relative to the endothelial monolayer (above or below, with “above” defined as any
monocyte having a majority of its cell body at or above the focal
plane of the endothelial cell nuclei).
Visualization of LBRC during TEM (referred to as targeted
recycling) was performed as described previously (Mamdouh
et al., 2009; Watson et al., 2015; Weber et al., 2015). For this
assay, we first tagged total PECAM (LBRC and surface) on
cytokine-activated endothelial cells with anti-PECAM F(ab)
fragments that are not function-blocking and then masked the
surface pool with unlabeled F(ab9)2 secondary antibodies at 4°C.
After adding PBMCs and fluorescently labeled F(ab9)2 secondary
antibody, samples were warmed for 10 min to allow synchronized TEM. Because this assay is brief and performed under
static conditions, most lymphocytes do not bind and are washed
away. The relatively few lymphocytes that do bind are easily
identified by their morphology and are not scored. During the
10-min incubation, monocytes bind and trigger the recruitment
of the LBRC, which then exposes the previously unblocked
primary epitopes contained within it. These epitopes can then be
bound by the fluorescent secondary antibodies, and thus, when
imaged using confocal microscopy, the recruitment of the LBRC
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is observed as increased fluorescence signal adjacent to migrating monocytes (Fig. 3 A). Leukocytes are visualized by
staining with Dylight 649–conjugated anti-CD18 after fixation.
LBRC recruitment is scored by measuring the backgroundsubtracted fluorescence signal next to the monocyte compared
with the average background-subtracted signal at junctions
several microns away from the monocyte. LBRC recruitment
was scored as positive if at least two regions with a signal at least
1.5 times the uninvolved junction, although most leukocytes
have multiple regions or an even ring of enrichment. Events that
do not recruit the LBRC typically have a ratio of 1 ± 0.1; i.e., the
signal around the leukocyte is not higher than the signal of the
neighboring junctions.
Bone marrow chimeras
To focus on the role of endothelial cell IQGAP1 specifically, bone
marrow chimeras were used for the animal studies described
here using standard protocols (Duran-Struuck and Dysko, 2009;
Mahajan et al., 2015). WT and IQGAP1 knockout mice were lethally irradiated with a 1,000-cGy dose using a Gammacell 40
Exactor 137Cs irradiator and reconstituted with bone marrow
from C57BL/6 WT mice (or LysM+/GFP heterozygous mice for the
intravital studies). Bone marrow donors and recipients were
always matched according to gender. Recipients recovered for
1 mo to allow for complete reconstitution of their bone marrow
before being used in these experiments. Reconstitution was
confirmed with PCR (for presence of the WT IQGAP1 and LysMGFP alleles) and fluorescence imaging of a blood smear (for the
presence of the GFP neutrophils).
Croton oil dermatitis model and immunofluorescence staining
of whole-mount ears
Croton oil–induced inflammation was performed essentially as
described previously (Schenkel et al., 2004; Watson et al., 2015;
Sullivan et al., 2016) using 20 µl of 0.9% croton oil in a 4:1 solution of acetone/olive oil (carrier) and allowing 5 h to induce
inflammation. The contralateral ear was treated with carrier
only. After harvesting, fixing, permeablizing, and blocking, the
ear leaflets were stained with 1 µg/ml anti-MRP14 conjugated to
DyLight 488, 10 µg/ml anti-PECAM (clone 2H8) conjugated to
DyLight 550, and 1 µg/ml anti-collagen IV conjugated to DyLight
649. Images were collected as above using a 40× oil-immersion
lens (NA 1.0). Ears that received carrier alone were examined to
ensure that the inflammatory stimulus was active and specific.
For the inflamed ears, at least eight fields per ear were imaged,
which typically corresponded to >100 neutrophils counted
per mouse.
IVM of the mouse cremaster
Preparation of the cremaster muscle for visualization using
fluorescence microscopy was performed essentially as described
previously (Thompson et al., 2001; Sumagin and Sarelius, 2007;
Woodfin et al., 2011; Sullivan et al., 2016). Briefly, male mice
between 8 and 12 wk old were injected intrascrotally with 50 ng
mouse recombinant IL-1β (R&D Systems) and 100 mg DyLight
550–conjugated nonblocking rat anti-mouse PECAM (clone 390)
in a final volume of 100 µl 4 h before exteriorization and
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visualization of the cremaster muscle. The tissue was visualized
using an Ultraview Vox imaging system equipped with a Yokogawa CSU-1 spinning disk and a 20× water-immersion objective (NA = 1.00). Images (Fig. 10 and Videos 1 and 2) were
collected using Volocity software (Perkin Elmer) and analyzed
using ImageJ (Schneider et al., 2012). Fields containing postcapillary venules with normal flow were identified using brightfield illumination. Ideal fields were those containing a relatively
straight 30–50-µm postcapillary venule with robust steady flow.
Three separate sets of images were collected for each field. First,
a 3D stack in the red (anti-PECAM, endothelial junctions)
channel was captured to determine the vessel dimensions. Then,
in the green (LysM-GFP, neutrophils) channel, a 60-s, singleplane recording (one frame per second) was captured near the
middle of the vessel to determine the rolling velocity and flux.
Lastly, a 30–60-min recording (four frames per second) of both
channels in 3D was captured to quantify TEM. After collecting
the recordings, the field was examined again using bright-field
illumination to check for any changes in flow rate. Fields that
had slowed or stopped flow during the acquisition or that appeared to have changed upon bright-field illumination after the
acquisition were not analyzed.
Image processing and data collection
The number of adherent neutrophils was calculated from the
60-s recording. Adherent neutrophils were identified as those
that did not move more than one cell diameter (∼5 µm) for ≥30 s
during the recording (Sumagin et al., 2008, 2011). Although the
recording only captured one plane (through the middle of the
vessel), adherent and rolling neutrophils were easily identified
in the adjacent, slightly out-of-focus planes by adjusting the
contrast levels. The total number of adherent neutrophils per
vessel surface area was calculated using the vessel dimensions
and modeling the vessel as a cylinder with open ends (vessel
surface area = πdl, where d is the average vessel diameter and l is
the vessel length). Rolling velocity was calculated by manually
tracking the distance individual neutrophils moved frame by
frame for those that rolled uninterrupted for ≥10 frames; rolling
velocity was only calculated from measurements collected while
the neutrophil was actively rolling. Rolling flux was calculated
by counting the number of neutrophils that rolled across an
arbitrary point in the vessel during the 60-s recording and dividing by the total number (rollers and those free in the
bloodstream) that passed the same point. TEM was calculated
from the long 4D recordings. TEM events were defined as those
in which the neutrophil traversed from clearly inside to clearly
outside of the vessel and separated from it. Neutrophils were
easily distinguished from monocytes based on morphology and
intensity (GFPhi). Furthermore, neutrophils are the predominant leukocyte subset recruited at the early time point of 4 h
after introduction of an inflammatory stimulus (Soehnlein et al.,
2009).
In vivo vascular permeability
The Miles assay measuring the vascular leakage of Evans Blue
was performed as described elsewhere (Schulte et al., 2011; Radu
and Chernoff, 2013). Briefly, 100 µl of 10 mg/ml Evans Blue in
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PBS was injected retro-orbitally. After 30 min, mice were sacrificed and tissue samples (one ear and a 1-cm circular piece of
dorsal skin) were collected. Samples were weighed and then
incubated with 0.5 ml formamide at 55°C for 24 h Absorbance at
620 nm of the supernatant was measured and the concentration
of Evans Blue calculated using a standard curve.
Statistical analysis
All in vitro experiments with quantitation were performed independently at least three times with at least three replicates for
each sample within each experiment. For the croton oil dermatitis experiments, each experiment contained at least three
mice for each condition. Average values within each experiment
were averaged between experiments to produce the data, and
standard deviations shown here. For the IVM experiments, the
data shown were compiled from three mice for each condition
with one recording for each mouse. For the transmigration assays, the values for the replicates were averaged together within
each experiment. The average and standard deviation of these
averages is shown in the figures. For each experimental, P values
were calculated from the average values using the Student’s
t test with a Bonferroni correction for unpaired observations.
Statistical differences are denoted by asterisks and denote P
values that can be found in the corresponding figure legend.
Online supplemental material
Supplemental figures show the expression and localization of
VE-cadherin (Fig. S1), ICAM-1 (Fig. S2), CD99 (Fig. S3), actin
(Fig. S4), and microtubules (Fig. S5) that are involved in various
steps in leukocyte recruitment and transmigration. None of the
molecules examined (VE-cadherin, ICAM, CD99, the actin cytoskeleton, or the microtubule network) were significantly altered in their abundance or distribution as a result of IQGAP1
knockdown or the reexpression of the relevant IQGAP1 constructs. Videos 1 and 2 are representative recordings of invivo leukocyte recruitment and TEM in WT and IQGAP1
knockout mice.
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